Cargando…
Effects of Natalizumab Therapy on Intrathecal Immunoglobulin G Production Indicate Targeting of Plasmablasts
OBJECTIVES: To evaluate the long-term effects of natalizumab (NTZ) on different features of intrathecal immunoglobulin (Ig) synthesis in patients with multiple sclerosis (MS) and to quantify the expression of α4-integrin in stages of B-cell maturation. METHODS: We combined a cross-sectional (49 NTZ-...
Autores principales: | Schlüter, Miriam, Oswald, Eva, Winklmeier, Stephan, Meinl, Ingrid, Havla, Joachim, Eichhorn, Peter, Meinl, Edgar, Kümpfel, Tania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265584/ https://www.ncbi.nlm.nih.gov/pubmed/34210800 http://dx.doi.org/10.1212/NXI.0000000000001030 |
Ejemplares similares
-
Relapse-independent multiple sclerosis progression under natalizumab
por: Graf, Jonas, et al.
Publicado: (2021) -
Neurological phenotypes in patients with NLRP3-, MEFV-, and TNFRSF1A low-penetrance variants
por: Mulazzani, Elisabeth, et al.
Publicado: (2020) -
Bridging, switching or drug holidays – how to treat a patient who stops natalizumab?
por: Havla, Joachim, et al.
Publicado: (2013) -
Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis
por: Ho, Samantha, et al.
Publicado: (2023) -
Persistence of functional memory B cells recognizing SARS-CoV-2 variants despite loss of specific IgG
por: Winklmeier, Stephan, et al.
Publicado: (2021)